Association of Aryl Hydrocarbon Receptor-Related Gene Variants with the Severity of Autism Spectrum Disorders by Takashi X. Fujisawa et al.
November 2016 | Volume 7 | Article 1841
Original research
published: 16 November 2016
doi: 10.3389/fpsyt.2016.00184
Frontiers in Psychiatry | www.frontiersin.org
Edited by: 
Ashok Mysore, 
St. John’s Medical College Hospital, 
India
Reviewed by: 
Kürs¸at Altınbas¸, 
Çanakkale Onsekiz Mart University, 
Turkey  
Meera Purushottam, 
National Institute of Mental Health 
and Neurosciences, India
*Correspondence:
Kazuyuki Shinohara  
kazuyuki@nagasaki-u.ac.jp
Specialty section: 
This article was submitted to Child 
and Adolescent Psychiatry, 
a section of the journal 
Frontiers in Psychiatry
Received: 05 July 2016
Accepted: 31 October 2016
Published: 16 November 2016
Citation: 
Fujisawa TX, Nishitani S, Iwanaga R, 
Matsuzaki J, Kawasaki C, Tochigi M, 
Sasaki T, Kato N and Shinohara K 
(2016) Association of Aryl 
Hydrocarbon Receptor-Related Gene 
Variants with the Severity of Autism 
Spectrum Disorders. 
Front. Psychiatry 7:184. 
doi: 10.3389/fpsyt.2016.00184
association of aryl hydrocarbon 
receptor-related gene Variants  
with the severity of autism  
spectrum Disorders
Takashi X. Fujisawa1,2, Shota Nishitani1, Ryoichiro Iwanaga3, Junko Matsuzaki4,  
Chisato Kawasaki5, Mamoru Tochigi6, Tsukasa Sasaki7, Nobumasa Kato8 and  
Kazuyuki Shinohara1*
1 Department of Neurobiology and Behavior, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 
2 Research Center for Child Mental Development, University of Fukui, Fukui, Japan, 3 Department of Occupational Therapy, 
Graduate School of Health Sciences, Nagasaki University, Nagasaki, Japan, 4 Nagasaki Municipal Welfare Center for the 
Handicapped, Nagasaki, Japan, 5 Sasebo Child Development Center, Sasebo, Japan, 6 Department of Neuropsychiatry, 
Teikyo University School of Medicine, Tokyo, Japan, 7 Department of Physical and Health Education, Graduate School of 
Education, The University of Tokyo, Tokyo, Japan, 8 Medical Institute of Developmental Disabilities Research, Showa 
University, Tokyo, Japan
Exposure to environmental chemicals, such as dioxin, is known to have adverse effects on 
the homeostasis of gonadal steroids, thereby potentially altering the sexual differentiation 
of the brain to express autistic traits. Dioxin-like chemicals act on the aryl hydrocarbon 
receptor (AhR), polymorphisms, and mutations of AhR-related gene may exert patholog-
ical influences on sexual differentiation of the brain, causing autistic traits. To ascertain 
the relationship between AhR-related gene polymorphisms and autism susceptibility, we 
identified genotypes of them in patients and controls and determined whether there are 
different gene and genotype distributions between both groups. In addition, to clarify the 
relationships between the polymorphisms and the severity of autism, we compared the 
two genotypes of AhR-related genes (rs2066853, rs2228099) with the severity of autistic 
symptoms. Although no statistically significant difference was found between autism 
spectrum disorder (ASD) patients and control individuals for the genotypic distribution 
of any of the polymorphisms studied herein, a significant difference in the total score of 
severity was observed in rs2228099 polymorphism, suggesting that the polymorphism 
modifies the severity of ASD symptoms but not ASD susceptibility. Moreover, we found 
that a significant difference in the social communication score of severity was observed. 
These results suggest that the rs2228099 polymorphism is possibly associated with the 
severity of social communication impairment among the diverse ASD symptoms.
Keywords: autism spectrum disorder, aryl hydrocarbon receptor, aryl hydrocarbon receptor nuclear translocator, 
polymorphism, social communication, severity
Abbreviations: AhR, aryl hydrocarbon receptor; ARNT, aryl hydrocarbon receptor nuclear translocator; ASD, autism spectrum 
disorder; CARS, Childhood Autism Rating Scale; DSM, diagnostic and statistical manual of mental disorders; EMB, extreme 
male brain; IQ, intelligence quotient; PBDE, polybrominated diphenyl ether; PCDD/Fs, polychlorinated dibenzo-p-dioxins and 
dibenzofurans; PCB, polychlorinated biphenyl; SNP, single nucleotide polymorphisms; TCDD, tetrachlorodibenzo-p-dioxin.
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inTrODUcTiOn
Reports of the incidence of autism spectrum disorder (ASD) – 
characterized by two core symptoms: communication and social 
deficits and fixed or repetitive behavior (1) – have been increasing 
in recent years (2). The prevalence of ASD rose from 1 per 5,000 
children in 1975 to 1 per 110 children in 2009 in the United States 
(3). Current estimates of the break up of possible reasons are as 
follows: about 25%, attributed to diagnostic accretion; 15%, to the 
growing awareness of ASD; 10%, to advanced parental age; and 
4%, to geographic clustering. However, for the remaining 46% of 
the cases, the underlying reasons remain unclear (3). Although a 
strong genetic contribution to ASD has been suggested by many 
previous studies (4, 5), the syndrome has many features that are 
not well explained by genetic factors alone (6). Therefore, some 
researchers have considered projecting ASD as a multifactorial 
disorder with both genetic and environmental influences (7–9).
The “extreme male brain” (EMB) theory is one of the lead-
ing hypotheses for explaining the mechanism of ASD (10, 11). 
The EMB theory suggests that exposure to imbalanced levels of 
gonadal steroids (androgen and estrogen) could exert a patho-
logical influence on the sexual differentiation of the brain during 
the fetal period, which may cause ASD traits in such individuals. 
Prenatal gonadal steroid levels in the amniotic fluid are correlated 
with ASD traits in children at 12 and 24 months of age (12, 13). 
Exposure to environmental chemicals, especially dioxin-like 
chemicals, is known to have adverse effects on the homeostasis 
of gonadal steroids, thereby altering the sexual differentiation of 
the brain to express ASD traits. Dioxin-like chemicals, such as 
tetrachlorodibenzo-p-dioxin (TCDD), polychlorinated dibenzo-
p-dioxins and dibenzofurans (PCDD/Fs), and some polychlorin-
ated biphenyls (PCBs), act on the aryl hydrocarbon receptor 
(AhR) (14, 15). Recent accumulating evidence suggests that 
ligand-activated AhR might alter both estrogen and androgen 
signals (16, 17). These findings further support that dioxin-like 
chemical exposure during the fetal period may exert pathologi-
cal influences on sexual differentiation of the brain, causing ASD 
traits (18).
Epidemiological studies have shown that PCB exposure at 
low levels can exert adverse clinical and subclinical effects on 
sociocognitive functions (19–23). Depending on geographical 
location, children might be exposed varying background levels 
of toxic environmental chemicals. Whether the adverse effects are 
expressed or not depends on inherent individual vulnerability to 
the environmental chemicals. Therefore, with regard to dioxin-
like chemicals in particular, the vulnerability could be modified 
by an individual’s receptor (AhR)-related gene polymorphisms.
Numerous studies have investigated the association between 
AhR-related gene polymorphisms and reproductive system 
diseases, such as endometriosis or infertility (24–27), because 
these diseases are regarded as complex traits in which genetic and 
environmental factors contribute to the disease phenotype (28). 
Various studies on AhR-related gene polymorphisms, as explored 
by a recent meta-analysis on endometriosis risk in Asian popula-
tions (27), have considered AhR Arg554Lys and AhR nuclear 
translocator (ARNT) Val189Val as potential candidates (24–27). 
Although it may be hypothesized that these two polymorphisms 
contribute to the ASD phenotype by modulating vulnerability to 
the environmental chemicals, little evidence is available on the 
relationship between ASD and AhR-related gene polymorphisms 
in humans, with the exception of the investigation on ARNT2 
polymorphisms (29). Therefore, the current study aimed to 
determine whether polymorphisms of AhR-related genes (AhR 
Arg554Lys and ARNT Val189Val) contribute to ASD susceptibil-
ity and/or severity.
First, to ascertain the relationship between the two AhR-related 
gene polymorphisms and ASD susceptibility, we identified these 
genotypes in patients and controls and determined whether there 
are different gene and genotype distributions between the two 
groups. Second, to clarify the relationships between the polymor-
phisms and the severity of ASD, we compared the genotypes of 
AhR-related genes with the severity of ASD symptoms using the 
Childhood Autism Rating Scale (CARS) (30). Finally, we applied 
factor analysis to the CARS scale and tried to identify several 
core symptoms, such as social communication, stereotypies, and 
sensory abnormalities (31). We also tried to evaluate the relation-
ship between the severity of these symptoms and the AhR-related 
gene polymorphisms because the disease severity is not always 
consistent across symptoms; rather, the relative severity of differ-
ent symptoms varies among individual cases (32, 33).
MaTerials anD MeThODs
Participants
Ninety-five children and adults with ASD participated in the 
present study. Participants with ASD were recruited in two dif-
ferent geographical regions, Tokyo and Nagasaki, in Japan. The 
participants in Tokyo consisted of 68 ASD patients (58 males and 
10 females, mean age =  12.43 ±  7.7  years) and were recruited 
from the outpatient clinics of the Department of Psychiatry in 
the University of Tokyo Hospital. The participants in Nagasaki 
consisted of 27 ASD patients (26 male and 1 female patients, 
mean age =  11.35 ±  3.2  years), and they were recruited from 
two day-care facilities in Nagasaki prefecture for patients with 
developmental disorders. In both areas, the diagnoses were made 
by two or more senior pediatric-psychiatric clinicians through 
structured interviews and reviews of clinical records according 
to the DSM-IV criteria (34). Among the 68 patients in Tokyo, 66 
were diagnosed with autistic disorder and 2 with Asperger’s disor-
der. Among the 27 patients in Nagasaki, 17 were diagnosed with 
autistic disorder and 10 with Asperger’s disorder. Both patient 
groups excluded individuals with pervasive developmental 
disorder, not otherwise specified (PDD-NOS). Participants with 
severe intellectual disability were excluded if they had a full-scale 
intelligence quotient (FSIQ) <50 on the Wechsler Intelligence 
Scale for Children (35), Wechsler Adult Intelligence Scale (36), 
or the Tanaka–Binet Intelligence Scale (a Japanese revised version 
of the Stanford–Binet Intelligence Scale) (37).
Additionally, 527 adults (332 men and 195 women patients, 
mean age =  40.9 ±  9.7  years) were recruited as control par-
ticipants from the nearby community around the University 
of Tokyo Hospital, without any psychiatric disorder disturbing 
their work function. The Mini-International Neuropsychiatric 
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Interview (MINI) (38) and other surveys were administered in 
the recruitment of controls to exclude those who had current 
or lifetime history of mental disorders. These individuals were 
recruited from the community through advertisements as well as 
an online solicitation.
The race/ethnicity of all participants was Japanese. Potential 
participants were also excluded if they had any history of 
substance abuse, recent substance use, head trauma with loss 
of consciousness, significant fetal exposure to alcohol or drugs, 
perinatal or neonatal complications, and neurological disorders 
or medical conditions.
The present study was approved by the Ethical Committees 
of the University of Tokyo Graduate School of Medicine and the 
Nagasaki University Graduate School of Biomedical Sciences. All 
participants or parents of the affected individuals provided writ-
ten informed consent prior to their participation in this study. 
The experimental protocol was conducted in accordance with the 
Declaration of Helsinki.
assessment of the severity of asD
The severity of ASD was assessed on the basis of the Japanese ver-
sion of the CARS (30). The assessment by CARS was performed at 
the same time as genomic sampling in this study. The CARS is a 
behavior-based clinical scale developed by observation and inter-
action with ASD patients. The scale has been reported to have 
a high degree of internal consistency, inter-rater and test–retest 
reliability, high criterion-related validity, and good discriminant 
validity (39). The severity was rated for 15 items (“Relationship 
to People,” “Imitation,” “Emotional Response,” “Body Use,” 
“Object Use,” “Adaptation to Change,” “Visual Response,” 
“Listening Response,” “Taste, Smell, Touch Response and Use,” 
“Fear and Nervousness,” “Verbal Communication,” “Non-verbal 
Communication,” “Activity Level,” “Level and Consistency of 
Intellectual Response,” and “General Impressions”) on a scale of 
1 (normal for child’s age) to 4 (severely abnormal) in units of 0.5. 
In this study, experienced clinical psychologists rated the subjects 
based on behavioral observation and parental reports.
genotyping
Genomic DNA was extracted from the peripheral blood using the 
standard phenol–chloroform method for set A and from the oral 
mucosa of the participants using the QIAamp DNA Micro Kit 
(Qiagen, Tokyo, Japan) in set B. All participants were genotyped 
by real-time polymerase chain reaction (PCR) analysis using 
Roche LightCycler 480 II (Roche Diagnostics, Tokyo, Japan) for 
the following two single nucleotide polymorphisms (SNPs): AhR 
codon 554 in exon 10 (G/A, Arg to Lys, rs2066853) and ARNT 
codon 189 in exon 7 (G/C, silent mutation, rs2066853) (24–28). 
Reactions were performed in 5-μl reactions, each containing 5 ng 
genomic DNA, 2.75 μl HPLC water, 0.25 μl of each TaqMan probe 
(Applied Biosystems, Foster City, CA, USA), and 2.5 μl TaqMan 
PCR Master Mix (Applied Biosystems, Foster City, CA, USA). 
The PCR cycling conditions consisted of a 10-min cycle at 95°C, 
followed by 60 cycles of 95°C for 30  s and 60°C for 30  s. Five 
microliters of HPLC water and Mater Mix were used as a negative 
PCR control in each amplification. Allele calling was performed 
using LightCycler CW 1.5 software (Roche Diagnostics).
Data analysis
Analyses proceeded in four steps. First, the chi-squared test was 
used to investigate the relationship between each AhR-related 
gene polymorphism and susceptibility to ASD. Next, analysis 
of variance (ANOVA) was used to compare the severity of ASD 
among AhR-related gene polymorphisms. Third, to assess the 
severity corresponding to several core behavioral symptoms 
of ASD, factor analysis with Varimax rotation for CARS was 
performed, and the factor score was calculated by regression 
method for each subject. Finally, ANOVA was also used to assess 
the effects of AhR-related gene polymorphisms for each severity 
of discriminative behavioral symptoms of ASD identified by the 
prior factor analysis. The chi-squared test, factor analysis, and 
multinomial logistic regression analysis were performed using 
IBM SPSS 20.0 for Windows (Statistical Package for the Social 
Sciences; IBM). The ANOVA was performed using Anovakun 
software (version 4.8.0.1) in the R software space (version 3.2.0. 
for Windows, R2).
resUlTs
genotypes of AhR-related genes and 
susceptibility to and severity of asD
The genotype and allele frequencies of AhR codon 554 and ARNT 
codon 189 are shown in Table 1. Fourteen samples with ARNT 
codon 189 in healthy participants were excluded from the data 
because the signal failed to be detected as a result of misamplifica-
tion. The genotype distributions were in Hardy–Weinberg equi-
librium (p > 0.05). Comparisons between genotype groups did 
not demonstrate statistically significant differences with regard 
to children’s age, sex, or IQ level. To investigate the relationship 
between each AhR-related gene polymorphism and susceptibility 
to ASD, the chi-squared test was used to evaluate the genotype 
distribution according to developmental status. No statistically 
significant association was observed between any of the polymor-
phisms and susceptibility to ASD.
Next, to investigate the relationship between each AhR-related 
gene polymorphism and the severity of ASD, one-way ANOVA 
was used for the total CARS score of ASD patients as the dependent 
variable and the genotype of each AhR-related gene polymorphism 
as the independent variable. There was a statistically significant 
difference between genotype groups for ARNT polymorphism 
(rs2228099), as determined by ANOVA [F(2,92) = 5.69, p < 0.01, 
effect size f = 0.352, power = 0.865]. Holm’s sequentially rejective 
Bonferroni post hoc test revealed that the total CARS score of the 
GG genotype was statistically significantly higher than those of 
the GC genotypes [t(92) = 3.17, p < 0.05], whereas there were no 
statistically significant differences in score between the CC geno-
type and both genotype groups [GC-CC: t(92) = 2.18; GG-CC: 
t(92) = 0.10]. Additionally, there were no statistically significant 
differences between genotype groups for AhR polymorphism 
(rs2066853) [F(2,92) = 0.26]. Taken together, these results suggest 
1 http://riseki.php.xdomain.jp.
2 https://www.r-project.org/.
TaBle 2 | Factor loadings from factor analysis with Varimax rotationa, mean, and sD of the 15 items of the cars.
cars item Factor M (sD)
social communication sensory and emotional response stereotypies
Verbal communication 0.833 2.46 (0.8)
Non-verbal communication 0.563 2.37 (0.7)
Imitation 0.561 2.03 (0.8)
Visual response 0.457 0.456 2.08 (0.8)
Relating to people 0.447 0.446 2.70 (0.7)
Level and consistency of intellectual response 0.419 2.55 (0.7)
Activity level 0.642 2.16 (0.7)
Object use 0.459 0.539 1.98 (0.7)
Emotional response 0.511 2.68 (0.7)
Taste, smell, touch response and use 0.505 1.97 (0.6)
Listening response 0.504 2.12 (0.6)
Fear or nervousness 0.360 2.34 (0.6)
General impressions 0.365 0.732 2.94 (0.6)
Adaptation to change 0.549 2.36 (0.6)
Body use 0.396 0.391 0.430 2.34 (0.5)
aOnly factor loadings >0.35 are reported.
TaBle 1 | genotype and allele frequencies of AhR and ARNT polymorphisms.
asD control asD control
genotype n % n % allele n % n %
AhR (rs2066853)
GG 24 25.3 160 30.4 G 102 53.7 579 54.9
GA 54 56.8 259 49.1 A 88 46.3 475 45.1
AA 17 17.9 108 20.5
Total 95 100.0 527 100.0 190 100.0 1054 100.0
ARNT (rs2228099)
GG 39 41.1 189 35.9 G 120 63.2 624 60.8
GC 42 44.2 246 46.7 C 70 36.8 402 39.2
CC 14 14.7 78 14.8
Total 95 100.0 513a 100.0 190 100.0 1026a 100.0
a14 samples with ARNT polymorphism from control participants were excluded from the data because the signal failed to be detected as a result of misamplification.
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that ARNT polymorphism modified the severity of ASD among 
the AhR-related genes examined in the current study.
Factor analysis of cars
To assess the severity according to several core behavioral symp-
toms of ASD, factor analysis with Varimax rotation was performed 
for the CARS data. The analysis produced three factors with 
eigenvalues greater than one. These factors accounted for 55.1% of 
the common variance. Table 2 shows the factor loadings and the 
descriptive statistics for each item of the CARS data. The first fac-
tor was “social communication,” which consisted of “verbal com-
munication,” “non-verbal communication,” “imitation,” “visual 
response,” “relating to people,” and “level and consistency,” and 
assessed the proficiency of social communication and reciprocity. 
The second factor was “sensory and emotional response,” which 
consisted of “activity level,” “object use,” “emotional response,” 
“taste, smell, touch, and response,” “listening response,” and 
“fear or nervousness,” and assessed abnormalities of sensory and 
emotional responses. The third factor was “stereotypies,” which 
consisted of “total impression,” “adaptation to change,” and “body 
use” and assessed restricted, repetitive patterns of behavior. These 
three factors well recapitulated the core behavioral symptoms of 
ASD, as described by the DSM-5, and the results were consistent 
to those of a similar previous study applying a factor analysis to 
CARS data (31). Therefore, we used the factor score for each of the 
three factors in the association analysis between the genotype of 
AhR-related genes and the severity of each of the three behavioral 
symptoms of ASD.
genotypes of AhR-related genes and the 
severity of the core Behavioral symptoms 
of asD
To investigate relationship between each AhR-related gene poly-
morphism and the severity of several of the core symptoms of ASD, 
one-way ANOVA was performed for the factor score of CARS of 
ASD patients as the dependent variable, with the genotype of each 
AhR-related gene polymorphism as the independent variable. 
Similar to the result for the total score, there were no statisti-
cally significant associations between factor scores and genotype 
TaBle 3 | genotype frequencies of AhR and ARNT polymorphisms.
social communication sensory and emotional response stereotypies
AhR (rs2066853)
Genotype GG GA AA GG GA AA GG GA AA
n 24 54 17 24 54 17 24 54 17
CARS score M −0.11 0.06 −0.04 −0.01 −0.05 0.16 −0.04 −0.07 0.28
SD (0.9) (0.9) (0.9) (1.0) (0.8) (0.6) (0.8) (0.8) (1.0)
ANOVA F 0.35 0.40 1.15
p 0.704 0.670 0.320
Effect size f 0.088 0.094 0.158
Power 0.107 0.116 0.255
ARNT (rs2228099)
Genotype GG GC CC GG GC CC GG GC CC
n 39 42 14 39 42 14 39 42 14
CARS score M 0.32 −0.29 −0.01 0.13 −0.17 0.15 0.02 −0.13 0.34
SD (1.0) (0.7) (0.9) (0.8) (0.6) (1.1) (0.8) (0.8) (0.8)
ANOVAa F 5.29 1.68 1.72
p 0.007* 0.191 0.185
Effect size f 0.339 0.191 0.193
Power 0.838 0.356 0.363
aThe statistical threshold was set at corrected *p < 0.05 (0.05/6 = 0.0083…) with the Bonferroni adjustment for multiple comparisons.
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groups for AhR polymorphism (rs2066853) (Table 3). However, 
for ARNT polymorphism (rs2228099), a significant difference 
was observed for the factor score of the “social communication” 
factor, but not for the “sensory and emotional response” factor 
or “stereotypies” factor. Holm’s sequentially rejective Bonferroni 
post hoc test revealed that the factor score of the GG genotype 
was statistically significantly higher than that of the GC geno-
types [t(92) = 3.25, p < 0.01], whereas there were no statistically 
significant differences in score between CC genotype and both 
genotype groups [GC-CC: t(92) =  1.24; GG-CC: t(92) =  1.09] 
(Figure 1).
DiscUssiOn
In this study, no statistically significant difference was found 
between ASD patients and control individuals for the geno-
typic distribution of any of the polymorphisms studied herein. 
However, a significant difference in the severity score, especially 
for the symptom of “social communication,” was observed in 
ARNT codon 189 polymorphism, suggesting that the ARNT 
polymorphism modifies the severity of ASD symptoms but not 
susceptibility to ASD.
A large twin population study estimated that environmental 
factors common to twins explain about 55% of the liability to 
ASD, while genetic factors explain 35% (9). As one of the envi-
ronmental factors for the liability to ASD, the possible involve-
ment of dioxin and/or dioxin-like environmental chemicals 
was investigated. Although many environmental chemicals 
affect neurodevelopment in humans, we focused on dioxin and 
dioxin-like chemicals because we have shown that higher levels of 
dioxin-like PCBs in the cord blood appear as a manifestation of 
ASD-like behaviors in 4-month-old infants (40), and also because 
maternal exposure to such environmental chemicals possibly dis-
rupts fetal gonadal hormone balances, which could lead to EMB 
(12, 13). The current study investigated the effects of AhR-related 
gene polymorphisms on ASD susceptibility and/or severity to 
determine the relationship between possible vulnerability to 
dioxin and dioxin-like PCBs and ASD susceptibility and/or sever-
ity because dioxin and dioxin-like PCBs at low levels have spread 
almost uniformly throughout the country. AhR-related gene 
polymorphisms have been found to underlie physical diseases 
such as breast cancer and endometriosis, but no report is available 
on the effect of these polymorphisms on mental disorders. To 
the best of our knowledge, the present study is the first report 
to clarify the association between ARNT, an AhR-related gene 
polymorphism, and the severity of ASD symptoms.
The current study could not clarify the mechanism underlying 
how the ARNT polymorphism modifies ASD severity in terms of 
social communication since no functional analysis of the ARNT 
polymorphism was carried out. However, a possible explanation 
is that this polymorphism might alter the gonadal hormone 
balance in the prenatal period through alterations in the AhR 
signaling pathway and could thus affect ASD severity. It is well 
known that the sexual differentiation of the human brain depends 
on prenatal exposure levels of androgens (41), and according to 
the EMB hypothesis, gonadal hormone imbalances make the 
autistic brain develop beyond that of the typical male (10, 11). In 
fact, evidence in favor of the positive association between autistic 
symptomatology and the levels of fetal testosterone has been found 
(13, 42). Although there is no evidence for a direct interaction 
between fetal testosterone and the AhR signaling pathway, the 
AhR–ARNT heterodimer has been reported to have estrogenic 
functions in the absence of estrogen (16). Therefore, some sort 
of functional variant induced by ARNT polymorphisms might 
alter the prenatal exposure levels of gonadal hormone and have 
adverse effects on sexual differentiation of the brain.
Our preliminary results showed a significant association 
between the severity of ASD and polymorphism at ARNT codon 
189, which results in a silent mutation (Val189Val). Although 
the exact molecular and physiological mechanisms underlying 
this effect remain unknown, a recent study suggested that silent 
mutations may contribute to mental disorders (43). Therefore, to 
FigUre 1 | Three factor scores of cars (mean ± se) for each 
polymorphism of AhR-related genes. The statistical threshold was 
corrected with Holm’s sequentially rejective Bonferroni adjustment for multiple 
comparisons. (a) AhR (rs2066853) and (B) ARNT (rs2228099). Note: 
**p < 0.01.
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clarify the possible meaning of this association, further genetic 
analyses are necessary. Such analyses should particularly address 
the interaction with other genetic polymorphisms, both upstream 
and downstream from rs2228099, which may interfere with splic-
ing and/or ARNT mRNA stability.
One of the most interesting findings in the current study is 
that the ARNT polymorphism is specifically associated with the 
severity of social communication impairment among the diverse 
ASD symptoms. The diversity of ASD symptoms is an obstacle 
for elucidating the pathology and etiology, and the core behav-
ioral symptoms defining ASD are genetically heterogeneous in 
that there are no overlapping genes acting on any of these traits. 
New, efficient models have been proposed to describe the diverse 
symptoms by evaluating the severity of the major components 
of impairments (44, 45). According to this strategy, we surmised 
that the ARNT polymorphism correlated with the severity of 
social communication difficulties but not with rigid and repeti-
tive behaviors.
Several limitations of the present study should be noted and 
taken into consideration in future studies. First, the main limita-
tion is the relatively small patient group. We did not observe a 
significant association between genetic SNPs and susceptibility to 
ASD in this study, and one possible explanation is the small sample 
number, as a large number of subjects are needed for case–control 
studies based on the frequency distribution. Therefore, studies 
involving a larger number of subjects are essential to generalize 
our results. Second, the number and age of subjects between the 
cases and control groups were not well matched. It is possible that 
the risk modulation by AhR-related gene polymorphism depends 
on the fetal environment and exposure of the mother, which 
would be expected to vary across different time periods. The 
disease risk imparted by the allele would therefore be expected 
to vary in different age groups. Third, although we have used the 
MINI to ensure the quality of the controls, it is important to note 
that the MINI does not necessarily exclude ASD. In addition, 
although the controls also need to be technically screened for 
family history of ASD or developmental disorders, MINI does 
not exclude individuals with unidentified Asperger’s or broader 
autism phenotypes, which is a key concern in the recruitment 
of controls in this study. In this regard, tools such as the Social 
Responsiveness Scale (SRS) may have provided a better index 
(46). This heterogeneity of our sample may be another possible 
explanation for our negative findings between groups described 
above. Finally, we used only one clinical scale (CARS) to assess 
the severity of ASD because we did not obtain full data for any 
other clinical scale. The ratings by CARS are not invariant across 
the life span (e.g., non-verbal ability in a 4-year-old individual 
may not be as severe as that in a 20-year-old individual), although 
the majority of our clinical samples consisted of children aged 
18 years and younger, and the genotype groups were confirmed 
to not be different with regard to age. However, the heterogeneity 
in age within our ASD samples could introduce a bias for severity 
assessment with respect to genetics, and it would also the affect 
factor analysis process. An informative measure such as SRS 
adjusted for age may have thus been more useful as a severity 
measure for purposes of this study (46). Therefore, future studies 
are needed to assess various aspects of behavioral symptoms of 
broad social communication using other established scales and to 
clarify the contribution of ARNT gene polymorphism to aspects 
of social communication.
cOnclUsiOn
In conclusion, the current results showed that individuals 
with the ARNT GG genotype had more severely impaired 
social communication than those with GC genotype in ASD, 
indicating that the differences in social functioning in ASD 
patients may be modulated by ARNT variants. Considering 
that ARNT is a component of AhR cascades, vulnerability to 
environment chemicals, especially dioxin-like chemicals may 
affect the severity of impaired social communication, although 
the functional analysis of ARNT gene polymorphism remains to 
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be performed. To identify the neuronal mechanism underlying 
this effect, combining the present experimental paradigm with 
neurophysiological indicators of brain activities is warranted in 
future studies.
aUThOr cOnTriBUTiOns
TF and SN were involved in conducting the experiment, analyz-
ing and interpreting data, and drafting the article. RI, JM, and 
CK were involved in recruiting the participants and diagnosing 
the participants with ASD. MT, TS, and NK were involved in 
conducting the experiment, analyzing and interpreting data, and 
revising the article. KS conceived of the study, participated in 
its design and coordination, and drafted the manuscript. All the 
authors have read and approved the final manuscript.
FUnDing
This work was supported by a Grant-in-Aid for Scientific Research 
(C) from the Ministry of Education, Culture, Sports, Science 
and Technology (MEXT) of Japan (KAKENHI: grant numbers 
25461774 to KS, grant number 15K01753 to TF).
reFerences
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5). 5th ed. Washington, DC: APA (2013).
2. Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, 
et al. Trends in the prevalence of developmental disabilities in US children, 
1997-2008. Pediatrics (2011) 127(6):1034–42. doi:10.1542/peds.2010-2989 
3. Weintraub K. The prevalence puzzle: autism counts. Nature (2011) 
479(7371):22–4. doi:10.1038/479022a 
4. Santangelo SL, Tsatsanis K. What is known about autism: genes, brain, 
and behavior. Am J Pharmacogenomics (2005) 5(2):71–92. doi:10.2165/ 
00129785-200505020-00001 
5. Freitag CM. The genetics of autistic disorders and its clinical relevance: a review 
of the literature. Mol Psychiatry (2007) 12(1):2–22. doi:10.1038/sj.mp.4001896 
6. Gillberg C, Coleman M. The Biology of the Autistic Syndromes (Clinics in 
Developmental Medicine). Cambridge, UK: Cambridge University Press 
(2000).
7. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying 
complex genetic traits: practical considerations. Nat Rev Genet (2002) 
3(5):391–7. doi:10.1038/nrg796 
8. Veenstra-Vanderweele J, Christian SL, Cook EH Jr. Autism as a paradigmatic 
complex genetic disorder. Annu Rev Genomics Hum Genet (2004) 5:379–405. 
doi:10.1146/annurev.genom.5.061903.180050 
9. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et  al. 
Genetic heritability and shared environmental factors among twin pairs 
with autism. Arch Gen Psychiatry (2011) 68(11):1095–102. doi:10.1001/
archgenpsychiatry.2011.76 
10. Baron-Cohen S. The extreme male brain theory of autism. Trends Cogn Sci 
(2002) 6(6):248–54. doi:10.1016/S1364-6613(02)01904-6 
11. Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the 
brain: implications for explaining autism. Science (2005) 310(5749):819–23. 
doi:10.1126/science.1115455 
12. Lutchmaya S, Baron-Cohen S, Raggatt P. Foetal testosterone and eye contact 
in 12 month old infants. Infant Behav Dev (2002) 25:327–35. doi:10.1016/
S0163-6383(02)00094-2 
13. Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, 
Hackett G, et  al. Fetal testosterone predicts sexually differentiated 
childhood behavior in girls and in boys. Psychol Sci (2009) 20(2):144–8. 
doi:10.1111/j.1467-9280.2009.02279.x 
14. Helmig S, Seelinger JU, Döhrel J, Schneider J. RNA expressions of AHR, 
ARNT and CYP1B1 are influenced by AHR Arg554Lys polymorphism. Mol 
Genet Metab (2011) 104(1–2):180–4. doi:10.1016/j.ymgme.2011.06.009 
15. Wahl M, Guenther R, Yang L, Bergman A, Straehle U, Strack S, et  al. 
Polybrominated diphenyl ethers and arylhydrocarbon receptor agonists: dif-
ferent toxicity and target gene expression. Toxicol Lett (2010) 198(2):119–26. 
doi:10.1016/j.toxlet.2010.06.001 
16. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, 
et  al. Modulation of oestrogen receptor signalling by association with the 
activated dioxin receptor. Nature (2003) 423(6939):545–50. doi:10.1038/
nature01606 
17. Del Pino Sans J, Clements KJ, Suvorov A, Krishnan S, Adams HL, Petersen SL. 
Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin may 
alter LH release patterns by abolishing sex differences in GABA/glutamate 
cell number and modifying the transcriptome of the male anteroventral 
periventricular nucleus. Neuroscience (2016) 329:239–53. doi:10.1016/ 
j.neuroscience.2016.04.051 
18. Ohtake F, Fujii-Kuriyama Y, Kato S. AhR acts as an E3 ubiquitin ligase to mod-
ulate steroid receptor functions. Biochem Pharmacol (2009) 77(4):474–84. 
doi:10.1016/j.bcp.2008.08.034 
19. Needleman HL. The future challenge of lead toxicity. Environ Health Perspect 
(1990) 89:85–9. doi:10.1289/ehp.908985 
20. Winneke G. Developmental aspects of environmental neurotoxicology: lessons 
from lead and polychlorinated biphenyls. J Neurol Sci (2011) 308(1–2):9–15. 
doi:10.1016/j.jns.2011.05.020 
21. Nishijo M, Tai PT, Nakagawa H, Maruzeni S, Anh NT, Luong HV, et al. Impact 
of perinatal dioxin exposure on infant growth: a cross-sectional and longi-
tudinal studies in dioxin-contaminated areas in Vietnam. PLoS One (2012) 
7(7):e40273. doi:10.1371/journal.pone.0040273 
22. Nowack N, Wittsiepe J, Kasper-Sonnenberg M, Wilhelm M, Schölmerich A. 
Influence of low-level prenatal exposure to PCDD/Fs and PCBs on empathiz-
ing, systemizing and autistic traits: results from the Duisburg birth cohort 
study. PLoS One (2015) 10(6):e0129906. doi:10.1371/journal.pone.0129906 
23. Tran NN, Pham TT, Ozawa K, Nishijo M, Nguyen AT, Tran TQ, et al. Impacts 
of perinatal dioxin exposure on motor coordination and higher cognitive 
development in Vietnamese preschool children: a five-year follow-up. PLoS 
One (2016) 11(1):e0147655. doi:10.1371/journal.pone.0147655 
24. Tsuchiya M, Katoh T, Motoyama H, Sasaki H, Tsugane S, Ikenoue T. Analysis 
of the AhR, ARNT, and AhRR gene polymorphisms: genetic contribution 
to endometriosis susceptibility and severity. Fertil Steril (2005) 84(2):454–8. 
doi:10.1016/j.fertnstert.2005.01.130 
25. Wu CH, Guo CY, Yang JG, Tsai HD, Chang YJ, Tsai PC, et al. Polymorphisms 
of dioxin receptor complex components and detoxification-related genes 
jointly confer susceptibility to advanced-stage endometriosis in the 
taiwanese han population. Am J Reprod Immunol (2012) 67(2):160–8. 
doi:10.1111/j.1600-0897.2011.01077.x 
26. Merisalu A, Punab M, Altmäe S, Haller K, Tiido T, Peters M, et  al. The 
contribution of genetic variations of aryl hydrocarbon receptor pathway 
genes to male factor infertility. Fertil Steril (2007) 88(4):854–9. doi:10.1016/ 
j.fertnstert.2006.12.041 
27. Zheng NN, Bi YP, Zheng Y, Zheng RH. Meta-analysis of the association of 
AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms 
and endometriosis risk in Asians. J Assist Reprod Genet (2015) 32(7):1135–44. 
doi:10.1007/s10815-015-0505-3 
28. Kennedy S. The genetics of endometriosis. Eur J Obstet Gynecol Reprod Biol 
(1999) 82(2):129–33. doi:10.1016/S0301-2115(98)00213-9 
29. Di Napoli A, Warrier V, Baron-Cohen S, Chakrabarti B. Genetic variant 
rs17225178 in the ARNT2 gene is associated with Asperger syndrome. Mol 
Autism (2015) 6:9. doi:10.1186/s13229-015-0009-0 
30. Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of 
childhood autism: childhood autism rating scale (CARS). J Autism Dev Disord 
(1980) 10(1):91–103. doi:10.1007/BF02408436 
31. Magyar CI, Pandolfi V. Factor structure evaluation of the childhood autism 
rating scale. J Autism Dev Disord (2007) 37(9):1787–94. doi:10.1007/
s10803-006-0313-9 
8Fujisawa et al. Autism Spectrum Disorders and AhR-Related Polymorphisms
Frontiers in Psychiatry | www.frontiersin.org November 2016 | Volume 7 | Article 184
32. Ronald A, Happé F, Bolton P, Butcher LM, Price TS, Wheelwright S, et  al. 
Phenotypic and genetic overlap between autistic traits at the extremes of the 
general population. J Am Acad Child Adolesc Psychiatry (2006) 45(10):1206–
14. doi:10.1097/01.chi.0000230165.54117.41 
33. Happé F, Ronald A, Plomin R. Time to give up on a single explanation for 
autism. Nat Neurosci (2006) 9(10):1218–20. doi:10.1038/nn1770 
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV). 4th ed. Washington, DC: APA (1994).
35. Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: 
Psychological Corporation (1991).
36. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: 
Psychological Corporation (1997).
37. Tanaka Institute for Educational Research. Tanaka Binet Chinou Kensa V 
[Tanaka-Binet Intelligence Scale V]. Tokyo: Taken Publishing (2003). (in 
Japanese).
38. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. 
The Mini-International Neuropsychiatric Interview (MINI): the development 
and validation of a structured diagnostic psychiatric interview for DSM-IV 
and ICD-10. J Clin Psychiatry (1998) 59:22–33. 
39. Parks LK, Hill DE, Thoma RJ, Euler MJ, Lewine JD, Yeo RA. Neural correlates 
of communication skill and symptom severity in autism: a voxel-based mor-
phometry study. Res Autism Spectr Disord (2009) 3(2):444–54. doi:10.1016/j.
rasd.2008.09.004 
40. Doi H, Nishitani S, Fujisawa TX, Nagai T, Kakeyama M, Maeda T, et  al. 
Prenatal exposure to a polychlorinated biphenyl (PCB) congener influences 
fixation duration on biological motion at 4-months-old: a preliminary study. 
PLoS One (2013) 8(3):e59196. doi:10.1371/journal.pone.0059196 
41. McCarthy MM, Arnold AP. Reframing sexual differentiation of the brain. Nat 
Neurosci (2011) 14(6):677–83. doi:10.1038/nn.2834 
42. Auyeung B, Taylor K, Hackett G, Baron-Cohen S. Foetal testosterone and 
autistic traits in 18 to 24-month-old children. Mol Autism (2010) 1(1):11. 
doi:10.1186/2040-2392-1-11 
43. Takata A, Ionita-Laza I, Gogos JA, Xu B, Karayiorgou M. De novo synon-
ymous mutations in regulatory elements contribute to the genetic etiology 
of autism and schizophrenia. Neuron (2016) 89(5):940–7. doi:10.1016/ 
j.neuron.2016.02.024 
44. Gebregziabher M, Shotwell MS, Charles JM, Nicholas JS. Comparison of 
methods for identifying phenotype subgroups using categorical features data 
with application to autism spectrum disorder. Comput Stat Data Anal (2012) 
56(1):114–25. doi:10.1016/j.csda.2011.06.014 
45. Bitsika V, Sharpley CF, Orapeleng S. An exploratory analysis of the use of 
cognitive, adaptive and behavioural indices for cluster analysis of ASD 
subgroups. J Intellect Disabil Res (2008) 52(11):973–85. doi:10.1111/ 
j.1365-2788.2008.01123.x 
46. Constantino JN, Gruber CP. The Social Responsiveness Scale Manual. 2nd ed. 
Los Angeles: Western Psychological Services (2012).
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Fujisawa, Nishitani, Iwanaga, Matsuzaki, Kawasaki, Tochigi, 
Sasaki, Kato and Shinohara. This is an open-access article distributed under the 
terms of the Creative Commons Attribution License (CC BY). The use, distribution or 
reproduction in other forums is permitted, provided the original author(s) or licensor 
are credited and that the original publication in this journal is cited, in accordance 
with accepted academic practice. No use, distribution or reproduction is permitted 
which does not comply with these terms.
